| USP7 |
USP7, HAUSP: Ubiquitin carboxyl-terminal hydrolase 7 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.78 |
Evidence |
|
| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.78 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
TSHR |
IPI00386365 |
0.78 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.78 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.78 |
Evidence |
|
| TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.78 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.78 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.78 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.78 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.78 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.78 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.78 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.78 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.78 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.78 |
Evidence |
|
| BMX |
IPI00514142 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.78 |
Evidence |
|
| BMX |
IPI00514142 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.78 |
Evidence |
|
| BMX |
IPI00514142 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.78 |
Evidence |
|
| BMX |
IPI00514142 |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.78 |
Evidence |
|
| P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.78 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.78 |
Evidence |
|
| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.78 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.78 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.78 |
Evidence |
|